UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure

BJU international, 2006-08, Vol.98 (2), p.353-358

2006

Volltextzugriff (PDF)

76 - Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S36-S37

2022

Volltextzugriff (PDF)

Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S36-S37

2022

Volltextzugriff (PDF)

Interesting case of immunotherapy related pneumonitis presenting as radiation pneumonitis

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S77-S78

2021

Volltextzugriff (PDF)

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

European urology, 2016-03, Vol.69 (3), p.450-456

2016

Volltextzugriff (PDF)

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

The lancet oncology, 2023-03, Vol.24 (3), p.213-227

2023

Volltextzugriff (PDF)

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience

Annals of oncology, 2015-09, Vol.26 (9), p.1865-1870

2015

Volltextzugriff (PDF)

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

European journal of cancer (1990), 2017-12, Vol.87, p.75-83

2017

Volltextzugriff (PDF)

Identification of a microbiome signature predicting immune checkpoint inhibitor outcomes across multiple cancer types in the MITRE study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS2665-TPS2665

2021

Volltextzugriff (PDF)

SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

European urology, 2015-04, Vol.67 (4), p.599-602

2015

Volltextzugriff (PDF)

Thyroid atrophy in patients receiving sunitinib or pazopanib for the treatment of advanced renal cell carcinoma: A common but under-reported toxicity

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15577-e15577

2015

Volltextzugriff (PDF)

A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data

Future oncology (London, England), 2023-01, Vol.19 (1), p.61-75

2023

Volltextzugriff (PDF)

Can dynamic changes in prognostic markers predict survival in patients receiving VEGF-targeted therapy in clear cell renal cell carcinoma?

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16061-e16061

2017

Volltextzugriff (PDF)

Comparison of cisplatin-based neoadjuvant chemotherapy for bladder cancer in elderly versus younger patients

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15502-e15502

2014

Volltextzugriff (PDF)

A randomized phase II study of AZ2014 versus everolimus in patients with VEGF refractory metastatic clear cell renal cancer (mRCC)

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.409-409

2015

Volltextzugriff (PDF)

Investigating serum β-HCG as an independent prognostic factor in patients (pts) receiving chemotherapy (Ct) for transitional cell carcinoma (TCC) of the urothelial tract

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4549-4549

2013

Volltextzugriff (PDF)

Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy

European urology focus, 2020-09, Vol.6 (5), p.999-1005

2020

Volltextzugriff (PDF)

Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks

Investigational new drugs, 2006-05, Vol.24 (3), p.223-231

2006

Volltextzugriff (PDF)

Efficacy and toxicity of anti-CD40 monoclonal antibodies for the treatment of malignancy

Geldart, Thomas Richard

2004

Volltextzugriff (PDF)

Chemotherapy for Testicular Cancer

Urological Cancers in Clinical Practice, p.187-212

Volltextzugriff (PDF)

Chemotherapy for Testicular Cancer

Urological Cancers, p.230-242

Volltextzugriff (PDF)

Identification of Two Mutations (F758W and F758Y) in the N-methyl-D-aspartate Receptor Glycine-binding Site that Selectively Prevent Competitive Inhibition by Xenon without Affecting Glycine Binding

Anesthesiology (Philadelphia), 2012-07, Vol.117 (1), p.38-47

2012

Volltextzugriff (PDF)

Progress in Ion Torrent semiconductor chip based sequencing

Electrophoresis, 2012-12, Vol.33 (23), p.3397-3417

2012

Volltextzugriff (PDF)

Novel Erythromycins from a Recombinant Saccharopolyspora erythraea Strain NRRL 2338 pIG1: I. Fermentation, Isolation and Biological Activity

The Journal of Antibiotics, 1998/11/25, Vol.51(11), pp.1029-1034

1998

Volltextzugriff (PDF)

"LANGUAGE NO TEST OF RACE."

The Reader, 1863-1867, 1863-09, Vol.2 (38), p.318-318

1863

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Male
(8)
Female
(6)
Treatment Outcome
(6)
Adult
(5)
Aged
(5)
Middle Aged
(5)
Oncology
(5)
Disease-Free Survival
(4)
Urology & Nephrology
(4)
Adolescent
(3)
Antineoplastic Agents - Adverse Effects
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Biological And Medical Sciences
(3)
Carcinoma, Renal Cell - Drug Therapy
(3)
Chemotherapy
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure

76 - Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer

Interesting case of immunotherapy related pneumonitis presenting as radiation pneumonitis

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

Identification of a microbiome signature predicting immune checkpoint inhibitor outcomes across multiple cancer types in the MITRE study

SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

Thyroid atrophy in patients receiving sunitinib or pazopanib for the treatment of advanced renal cell carcinoma: A common but under-reported toxicity

A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data

Can dynamic changes in prognostic markers predict survival in patients receiving VEGF-targeted therapy in clear cell renal cell carcinoma?

Comparison of cisplatin-based neoadjuvant chemotherapy for bladder cancer in elderly versus younger patients

A randomized phase II study of AZ2014 versus everolimus in patients with VEGF refractory metastatic clear cell renal cancer (mRCC)

Investigating serum β-HCG as an independent prognostic factor in patients (pts) receiving chemotherapy (Ct) for transitional cell carcinoma (TCC) of the urothelial tract

Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy

Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks

Efficacy and toxicity of anti-CD40 monoclonal antibodies for the treatment of malignancy

Chemotherapy for Testicular Cancer

Chemotherapy for Testicular Cancer

Identification of Two Mutations (F758W and F758Y) in the N-methyl-D-aspartate Receptor Glycine-binding Site that Selectively Prevent Competitive Inhibition by Xenon without Affecting Glycine Binding

Progress in Ion Torrent semiconductor chip based sequencing

Novel Erythromycins from a Recombinant Saccharopolyspora erythraea Strain NRRL 2338 pIG1: I. Fermentation, Isolation and Biological Activity

"LANGUAGE NO TEST OF RACE."

Suchergebnisse filtern